Look for:

Our offer for

QIAGEN NV


ISIN:
NL0012169213
WKN:
N72482123
2022/05/26 17:35:17
Price
42.59 EUR
Difference -0.49% (-0.21)

General attributes

ISINNL0012169213
SymbolQGEN
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)9,696 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open42.79 EUR
High42.88 EUR
Low42.35 EUR
Close (prev. day)42.80 EUR
VWAP42.5987 EUR
Volume (pcs)369,399
Trading volume15,735,917.62
Number of trades2,531
Last size129,444

Futures and Options

Related Futures17
Related Options-

PDF Downloads

Annual report: QIAGEN NVPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Erste Group related products on underlying

Product type # products
Turbos 9

Recent research



2022/05/26 17:35:17
Price
42.59 EUR
Difference -0.49% (-0.21)

General attributes

ISINNL0012169213
SymbolQGEN
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)9,696 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open42.79 EUR
High42.88 EUR
Low42.35 EUR
Close (prev. day)42.80 EUR
VWAP42.5987 EUR
Volume (pcs)369,399
Trading volume15,735,917.62
Number of trades2,531
Last size129,444

Performance and Risk

6M1Y3Y
Perf (%)-15.56%+5.42%+24.28%
Perf (abs.)-7.85+2.19+8.32
Beta0.480.380.29
Volatility26.5924.8232.31
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)42.76 EUR (428,362)
Ø price 30 days | Ø volume 30 days (pcs.)43.08 EUR (498,554)
Ø price 100 days | Ø volume 100 days (pcs.)43.33 EUR (676,357)
Ø price 250 days | Ø volume 250 days (pcs.)44.42 EUR (619,995)
YTD High | date49.34 EUR (2022/01/03)
YTD Low | date37.95 EUR (2022/03/08)
52 Weeks High | date51.56 EUR (2021/11/26)
52 Weeks Low | date37.95 EUR (2022/03/08)

Erste Group related products on underlying

Product type # products
Turbos 9

All listings for QIAGEN NV

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/05/2617:3542.59 EUR15.742,531
Vienna Stock Exchange2022/05/2617:3242.54 EUR0.002
Tradegate2022/05/2622:2642.51 EUR0.118
Stuttgart2022/05/2621:5542.49 EUR0.00140
SIX Swiss Exchange2019/06/2817:3539.45 CHF0.001
NYSE2022/05/2622:0045.63 USD21.278,129
Munich2022/05/2608:0042.41 EUR0.001
London Stock Exchange European Trade Reporting2022/05/2617:3042.525 EUR4.711
Hanover2022/05/2620:0042.38 EUR0.002
Hamburg2022/05/2620:0042.38 EUR0.002
Frankfurt2022/05/2615:1342.76 EUR0.002
Duesseldorf2022/05/2619:3042.37 EUR0.0019
Berlin2022/05/2608:0042.27 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1937&ID_TYPE_IMAGE_LOGO=2

Contact Details

QIAGEN NV
- -
Hulsterweg 82 - 5912 PL Venlo
Telefon: 31-77-355-66-00
Fax: 31-77-355-66-58
E-mail: qiagen@qiagen.com

PDF Downloads

Annual report: QIAGEN NVPDF Download

Company Profile

QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The firm automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D, and industrial applications, primarily forensics). The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Members of Management Board

Thierry BernardChairman of Managing Board
Barthold PieningMember of Executive Committee
Jonathan SheldonMember of Executive Committee
Thomas SchweinsMember of Executive Committee
Jean-Pascal ViolaMember of Executive Committee
Roland SackersMember of Executive Committee
Stephany FosterMember of Executive Committee

Board of directors

Lawrence RosenChairman of Supervisory Board
Elaine MardisMember of Supervisory Board
Metin ColpanMember of Supervisory Board
Ross LevineMember of Supervisory Board
Toralf HaagMember of Supervisory Board
Elizabeth TallettMember of Supervisory Board
Thomas EbelingMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.